5.00
-0.06(-1.19%)
Currency In USD
Previous Close | 5.06 |
Open | 5.2 |
Day High | 5.2 |
Day Low | 5 |
52-Week High | 9.14 |
52-Week Low | 1.91 |
Volume | 17,410 |
Average Volume | 222,393 |
Market Cap | 29.45M |
PE | -1 |
EPS | -4.99 |
Moving Average 50 Days | 3.88 |
Moving Average 200 Days | 2.88 |
Change | -0.06 |
If you invested $1000 in Vivos Therapeutics, Inc. (VVOS) since IPO date, it would be worth $22.51 as of January 15, 2025 at a share price of $5.06. Whereas If you bought $1000 worth of Vivos Therapeutics, Inc. (VVOS) shares 3 years ago, it would be worth $124.17 as of January 15, 2025 at a share price of $5.06.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Dec 23, 2024 1:00 PM GMT
LITTLETON, Colo., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective propr
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
GlobeNewswire Inc.
Oct 08, 2024 11:30 AM GMT
New Medical Codes will Facilitate Billing by Commercial Payers for Vivos CARE Treatment for Obstructive Sleep Apnea in Adults and ChildrenLITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDA
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.
Sep 19, 2024 11:00 AM GMT
LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective propr